Moneycontrol PRO
HomeNewsOmaxe

Omaxe

Jump to
  • Omaxe shares soar 13% as it acquires 260-acre land to develop new township in Amritsar

    Omaxe share price: The project has received RERA registration and all required approvals. In its first phase, the is offering residential plots in sizes of 300, 500, and 1,000 square yards.

  • Omaxe Consolidated March 2025 Net Sales at Rs 541.26 crore, up 1.06% Y-o-Y

    Omaxe Consolidated March 2025 Net Sales at Rs 541.26 crore, up 1.06% Y-o-Y

  • Omaxe Standalone March 2025 Net Sales at Rs 138.17 crore, down 18.02% Y-o-Y

    Omaxe Standalone March 2025 Net Sales at Rs 138.17 crore, down 18.02% Y-o-Y

  • Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March

    Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March

    Stocks to Watch, Mar 10: Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation, Container Corporation of India, Thangamayil Jewellery, Hinduja Global Solutions, IRB Infrastructure Developers, and AstraZeneca Pharma will be in focus on March 10.

  • Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March

    Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March

    Stocks to Watch, Mar 7: Stocks like Tamilnad Mercantile Bank, NMDC, Jindal Stainless, Sudarshan Pharma Industries, Brigade Enterprises, Rail Vikas Nigam, RITES, Laurus Labs, Bharat Electronics, InterGlobe Aviation, Firstsource Solutions, TCPL Packaging, Avanti Feeds, Campus Activewear, and Balaji Phosphates will be in focus on March 7.

  • Omaxe Consolidated December 2024 Net Sales at Rs 288.94 crore, down 51.78% Y-o-Y

    Omaxe Consolidated December 2024 Net Sales at Rs 288.94 crore, down 51.78% Y-o-Y

  • Omaxe Standalone December 2024 Net Sales at Rs 76.03 crore, down 65.54% Y-o-Y

    Omaxe Standalone December 2024 Net Sales at Rs 76.03 crore, down 65.54% Y-o-Y

  • Omaxe shares soar 4% on collaborative project plan with Rs 5,000 crore revenue potential

    Omaxe shares soar 4% on collaborative project plan with Rs 5,000 crore revenue potential

    The initiative will eye Joint Ventures, collaboration and development through Public-Private Partnerships (PPP) in spaces where infrastructure gaps exist, and can potentially drive socio-economic growth.

  • Omaxe Consolidated September 2024 Net Sales at Rs 389.18 crore, up 46.26% Y-o-Y

    Omaxe Consolidated September 2024 Net Sales at Rs 389.18 crore, up 46.26% Y-o-Y

  • Omaxe Standalone September 2024 Net Sales at Rs 95.35 crore, down 42.6% Y-o-Y

    Omaxe Standalone September 2024 Net Sales at Rs 95.35 crore, down 42.6% Y-o-Y

  • SAT stays Sebi's securities market ban on Omaxe, others

    SAT stays Sebi's securities market ban on Omaxe, others

    The fraud was never disclosed to the shareholders of Omaxe, which misled them to remain invested in its shares or deal in its securities.

  • Omaxe Group launches 'The Omaxe State' with Rs 2500 cr investment in Delhi’s Dwarka

    Omaxe Group launches 'The Omaxe State' with Rs 2500 cr investment in Delhi’s Dwarka

    The Omaxe State in Dwarka Sector 19B is expected to be completed by 2027 and will have a revenue development potential of Rs 4,200 crore. The project will be India’s first integrated 5-in-1 destination with sports, retail, hospitality, food and culture arena featuring a state-of-the-art cricket-cum-football stadium.

  • Omaxe Consolidated June 2024 Net Sales at Rs 341.61 crore, up 60.04% Y-o-Y

    Omaxe Consolidated June 2024 Net Sales at Rs 341.61 crore, up 60.04% Y-o-Y

  • Omaxe Standalone June 2024 Net Sales at Rs 80.30 crore, down 46.48% Y-o-Y

    Omaxe Standalone June 2024 Net Sales at Rs 80.30 crore, down 46.48% Y-o-Y

  • Omaxe may challenge Sebi order barring company, chairman, MD from securities market for 2 yrs

    Omaxe may challenge Sebi order barring company, chairman, MD from securities market for 2 yrs

    The Sebi order had a negative impact on the company's share prices. The stock of the company on Wednesday declined 4.99 per cent to Rs 152.20 apiece -- its lower circuit limit -- on the BSE.

  • Omaxe Consolidated March 2024 Net Sales at Rs 535.58 crore, up 85.02% Y-o-Y

    Omaxe Consolidated March 2024 Net Sales at Rs 535.58 crore, up 85.02% Y-o-Y

  • Omaxe Standalone March 2024 Net Sales at Rs 168.55 crore, up 1.47% Y-o-Y

    Omaxe Standalone March 2024 Net Sales at Rs 168.55 crore, up 1.47% Y-o-Y

  • Omaxe Consolidated December 2023 Net Sales at Rs 599.21 crore, up 145.72% Y-o-Y

    Omaxe Consolidated December 2023 Net Sales at Rs 599.21 crore, up 145.72% Y-o-Y

  • Omaxe shares locked at upper circuit as consortium wins projects to develop bus terminals in Ayodha, Lucknow

    Omaxe shares locked at upper circuit as consortium wins projects to develop bus terminals in Ayodha, Lucknow

    These Bus Terminals in Ayodhya and Lucknow will be developed under design, build, finance, operate and transfer (DBFOT) model on PPP basis.

  • Omaxe Standalone December 2023 Net Sales at Rs 220.64 crore, up 54.99% Y-o-Y

    Omaxe Standalone December 2023 Net Sales at Rs 220.64 crore, up 54.99% Y-o-Y

  • Omaxe posts Rs 72 crore loss for Dec quarter; reappoints Mohit Goel as MD

    Omaxe posts Rs 72 crore loss for Dec quarter; reappoints Mohit Goel as MD

    The Omaxe board also approved re-appointment of Mohit Goel as Managing Director of the company for a period of five years with effect from April 1, 2024 to March 31, 2029 subject to the approval of shareholders.

  • Realty firm Omaxe closes Rs 440-crore loan from Credit Solution before time

    Realty firm Omaxe closes Rs 440-crore loan from Credit Solution before time

    Omaxe has secured new financial assistance totalling Rs 450 crore from Kotak Mahindra Bank Limited and out of this amount, Rs 290 crore has been utilized to repay the facility initially obtained from Varde Partners and the remaining Rs 160 crore will be allocated for development of its projects.

  • Omaxe Consolidated September 2023 Net Sales at Rs 266.09 crore, up 123.83% Y-o-Y

    Omaxe Consolidated September 2023 Net Sales at Rs 266.09 crore, up 123.83% Y-o-Y

  • Omaxe Standalone September 2023 Net Sales at Rs 166.12 crore, up 141.17% Y-o-Y

    Omaxe Standalone September 2023 Net Sales at Rs 166.12 crore, up 141.17% Y-o-Y

  • Omaxe Consolidated June 2023 Net Sales at Rs 213.45 crore, up 76.23% Y-o-Y

    Omaxe Consolidated June 2023 Net Sales at Rs 213.45 crore, up 76.23% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347